Group items tagged

The American Association for the History of Nursing, Inc (AAHN) initiated a grant program in 2008. The H 15 Grant, for faculty members and independent researchers; and the H 31 Pre-doctoral Grant, designed to encourage and support graduate training and historical research at the Master's and Doctoral levels. The deadline for all Grants is April 1. Only AAHN members are eligible to apply for these grants.

The Oncology Nursing Society Foundation is seeking Letters of Intent from beginning researchers for its mentored Research Career Development Award. Through the annual program, grants of up to $20,000 will be awarded to support short-term oncology research training and mentorship, with each fellow receiving up to $18,000 to cover related expenses; the mentor (or the mentor's institution) will receive a $2,000 award in the form of an unrestricted honorarium to cover his/her consultative or research-related expenses and/or other institutional costs. To be eligible, applicants must be a registered nurse with an interest in oncology and have a completed PhD degree in nursing or a related discipline. The awards are available for beginning researchers (i.e., up to eight years after completing a PhD degree with no history of research funding as a principal investigator).

Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is characterized by chronic inflammation of gastrointestinal tract. In 2015, approximately three million US adults reported having a diagnosis of IBD and the estimated number has increased greatly from 1.8 million since 1999. While the exact cause is unknown, the severity and progression of the disease largely impacts the patients’ quality of life and imposes huge financial burden to the US healthcare system. The purpose of this announcement is to 1) establish a new IBD registry to estimate incidence of IBD in the adult and pediatric populations and extrapolate to the US population; 2) describe the natural history and outcomes of IBD; 3) determine racial/ethnic variation in the detection and management of IBD; and 4) identify evidence-based strategies to improve disease outcomes. The results are anticipated to enhance understanding of the impact of IBD on the overall health of affected persons and the impact of various clinical practices and healthcare delivery approaches on the disease outcomes.

1. Basic Science of Gene Therapy for Hemophilia * Basic science, tropism, transduction efficiency & tolerability of Adeno associated virus (AAV) * AAV antibody seroprevalence, titer- assessment, reduction & tolerance * Role of immunosuppression in managing immune response and potential retreatment * Effect of Gene Therapy on liver biology 2. Basic Science of TFPI & Anti-TFPI Monoclonal Antibodies * Basic biology of TFPI interactions with Protein C, ATIII & Protein S * Cross talk among regulators (e.g., Protein S being a co-factor for both Protein C and TFPI) * Role of different TFPI pools in regulation of coagulation * Impact of concomitant treatments (especially antifibrinolytics) added to anti-TFPI on the physiology of hemostasis * Note: Pfizer will not supply study drug 3. Burden of disease: Clinical Hemophilia A and B * Natural history of hemophilia and adherence to current standard of care * Arthropathy: presence, development, clinical burden & joint damage in hemophilia * Patient experiences with hemophilia, treatment preferences and quality of care * Quality of Life/Work analysis and cost of care in Hemophilia